CLINICAL_TRIALS
trial_result
· 2009-06-02
Clinical Trial Update: A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression. [Phase 3]
Summary
A completed Phase 3 study evaluating the efficacy and safety of Geodon (ziprasidone) in patients with Bipolar I Depression.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2009-06-02